NHI Quote, Financials, Valuation and Earnings

Medical Properties Trust has a net margin of 50.43% compared to National Health Investors's net margin of -178.07%. National Health Investors's return on equity of 10.72% beat Medical Properties Trust's return on equity of -39.12%.

National Health Investors has a consensus price target of $82.14, signalling upside risk potential of 11.29%. On the other hand Medical Properties Trust has an analysts' consensus of $5.50 which suggests that it could fall by -10.86%. Given that National Health Investors has higher upside potential than Medical Properties Trust, analysts believe National Health Investors is more attractive than Medical Properties Trust.

National Health Investors has a beta of 1.083, which suggesting that the stock is 8.267% more volatile than S&P 500. In comparison Medical Properties Trust has a beta of 1.324, suggesting its more volatile than the S&P 500 by 32.431%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.88%. Medical Properties Trust offers a yield of 8.75% to investors and pays a quarterly dividend of $0.08 per share. National Health Investors pays 113.43% of its earnings as a dividend. Medical Properties Trust pays out -13.32% of its earnings as a dividend.

National Health Investors quarterly revenues are $85.8M, which are smaller than Medical Properties Trust quarterly revenues of $231.8M. National Health Investors's net income of $43.2M is higher than Medical Properties Trust's net income of -$412.8M. Notably, National Health Investors's price-to-earnings ratio is 23.66x while Medical Properties Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.71x versus 3.72x for Medical Properties Trust. Usually stocks with elevated PS ratios are considered overvalued.

Omega Healthcare Investors has a net margin of 50.43% compared to National Health Investors's net margin of 40.58%. National Health Investors's return on equity of 10.72% beat Omega Healthcare Investors's return on equity of 9.91%.

National Health Investors has a consensus price target of $82.14, signalling upside risk potential of 11.29%. On the other hand Omega Healthcare Investors has an analysts' consensus of $41.00 which suggests that it could grow by 9.33%. Given that National Health Investors has higher upside potential than Omega Healthcare Investors, analysts believe National Health Investors is more attractive than Omega Healthcare Investors.

National Health Investors has a beta of 1.083, which suggesting that the stock is 8.267% more volatile than S&P 500. In comparison Omega Healthcare Investors has a beta of 1.003, suggesting its more volatile than the S&P 500 by 0.31000000000001%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.88%. Omega Healthcare Investors offers a yield of 7.15% to investors and pays a quarterly dividend of $0.67 per share. National Health Investors pays 113.43% of its earnings as a dividend. Omega Healthcare Investors pays out 168.69% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $85.8M, which are smaller than Omega Healthcare Investors quarterly revenues of $279.3M. National Health Investors's net income of $43.2M is lower than Omega Healthcare Investors's net income of $113.3M. Notably, National Health Investors's price-to-earnings ratio is 23.66x while Omega Healthcare Investors's PE ratio is 24.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.71x versus 9.65x for Omega Healthcare Investors. Usually stocks with elevated PS ratios are considered overvalued.

Regency Centers has a net margin of 50.43% compared to National Health Investors's net margin of 23.21%. National Health Investors's return on equity of 10.72% beat Regency Centers's return on equity of 5.69%.

National Health Investors has a consensus price target of $82.14, signalling upside risk potential of 11.29%. On the other hand Regency Centers has an analysts' consensus of $79.89 which suggests that it could grow by 10.69%. Given that National Health Investors has higher upside potential than Regency Centers, analysts believe National Health Investors is more attractive than Regency Centers.

National Health Investors has a beta of 1.083, which suggesting that the stock is 8.267% more volatile than S&P 500. In comparison Regency Centers has a beta of 1.228, suggesting its more volatile than the S&P 500 by 22.846%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.88%. Regency Centers offers a yield of 3.81% to investors and pays a quarterly dividend of $0.71 per share. National Health Investors pays 113.43% of its earnings as a dividend. Regency Centers pays out 125.88% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $85.8M, which are smaller than Regency Centers quarterly revenues of $372.5M. National Health Investors's net income of $43.2M is lower than Regency Centers's net income of $86.5M. Notably, National Health Investors's price-to-earnings ratio is 23.66x while Regency Centers's PE ratio is 34.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.71x versus 9.09x for Regency Centers. Usually stocks with elevated PS ratios are considered overvalued.

Welltower has a net margin of 50.43% compared to National Health Investors's net margin of 5.41%. National Health Investors's return on equity of 10.72% beat Welltower's return on equity of 3.21%.

National Health Investors has a consensus price target of $82.14, signalling upside risk potential of 11.29%. On the other hand Welltower has an analysts' consensus of $161.63 which suggests that it could grow by 10.89%. Given that National Health Investors has higher upside potential than Welltower, analysts believe National Health Investors is more attractive than Welltower.

National Health Investors has a beta of 1.083, which suggesting that the stock is 8.267% more volatile than S&P 500. In comparison Welltower has a beta of 1.203, suggesting its more volatile than the S&P 500 by 20.319%.

National Health Investors has a quarterly dividend of $0.90 per share corresponding to a yield of 4.88%. Welltower offers a yield of 1.79% to investors and pays a quarterly dividend of $0.67 per share. National Health Investors pays 113.43% of its earnings as a dividend. Welltower pays out 162.37% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

National Health Investors quarterly revenues are $85.8M, which are smaller than Welltower quarterly revenues of $2.2B. National Health Investors's net income of $43.2M is lower than Welltower's net income of $120M. Notably, National Health Investors's price-to-earnings ratio is 23.66x while Welltower's PE ratio is 93.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Health Investors is 9.71x versus 11.36x for Welltower. Usually stocks with elevated PS ratios are considered overvalued.